In the original article, there was a mistake in Figure 1A and Figure 1B as published. The location of Figure 1AandFigure 1Bis incorrect. The corrected Figure 1 appears below.
Figure 1
In the original article, there was an error. Matrigel matrix was pre-coated to the upper chamber for 4°C overnight and then cells 1×105 cultured in serum-free medium were placed in the upper chamber of transwell, and 20% serum-free medium were placed in the lower chamber.
A correction has been made to MATERIALS AND METHODS Transwell AssayParagraph 1
“The matrigel matrix was dissolved at 4°C, then added to the upper chamber of the pre-cooled transwell and incubated at 37°C for 2 h to solidify the matrigel matrix. Cells (1 × 105) were cultured in serum-free medium and placed in the upper chamber of transwell, and cultural medium with 20% fetal bovine serum (FBS) was placed in the lower chamber”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
esophageal cancer, miR-135b-5p, thioredoxin interacting protein, cisplatin, proliferation
Citation
Di Y, Jiang Y, Shen X, Liu J, Gao Y, Cai H, Sun X, Ning D, Liu B, Lei J and Jin S (2021) Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin. Front. Oncol. 11:785363. doi: 10.3389/fonc.2021.785363
Received
29 September 2021
Accepted
29 October 2021
Published
15 November 2021
Volume
11 - 2021
Edited and reviewed by
Huihui Fan, University of Texas Health Science Center at Houston, United States
Updates
Copyright
© 2021 Di, Jiang, Shen, Liu, Gao, Cai, Sun, Ning, Liu, Lei and Jin.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shizhu Jin, drshizhujin@hrbmu.edu.cn
†These authors have contributed equally to this work and share first authorship
This article was submitted to Thoracic Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.